Menthol for Dyspnea Relief in Health and COPD

Menthol inhalation (MI) is a novel and promising treatment option for acute relief of dyspnea, however, the underlying ventilatory and/or neural related mechanisms for this relief in symptoms remain unknown. The overall aim of this research project is to systematically examine the mechanisms of dyspnea relief from MI in healthy individuals and those with COPD.

NCT Number	NCT05785026
Lead Sponsor	KU Leuven
Conditions	Dyspnea, Chronic Obstructive Pulmonary Disease
Enrollment	120 participants
Start Date	2023-01-01
Primary Completion	2028-10-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-19